Finance

Lists
ARDX:NASDAQ
Ardelyx Inc
$3.09
-0.96%
(-0.030) 1D
$3.11
+0.65% (+0.020)
After hours
Closed: Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARDX...
Open
$3.14
High
$3.15
Low
$3.05
Mkt. cap
776.74M
Avg. vol.
4.88M
Volume
2.38M
52-wk high
$8.40
52-wk low
$2.80
EPS
-$0.22
Beta
0.79
Shares outstanding
251.37M
No. of employees
489
Open
$3.14
High
$3.15
Low
$3.05
Mkt. cap
776.74M
Avg. vol.
4.88M
Volume
2.38M
52-wk high
$8.40
52-wk low
$2.80
EPS
-$0.22
Beta
0.79
Shares outstanding
251.37M
No. of employees
489
News stories
From web sources and news partners
About Ardelyx Inc
CEOMike Raab
Employees489
Founded2007
Headquarters-
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 5 analysts giving stock ratings to ARDX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ARDX in the last 3 months.
Highest
Current $3.09
$18.00 (+482.52%)
Average
$12.40 (+301.29%)
Lowest
$8.00 (+158.90%)
Analyst
Recommendation
Action
Price target
Projected
Date
Julian Harrison
BTIG
Buy
Maintained
$11.00
+256%
11/09/2026
Joseph Thome
TD Cowen
Buy
Maintained
$10.00
+223.6%
11/04/2026
David Nierengarten
Wedbush
Buy
Maintained
$8.00
+158.9%
11/04/2026
Matthew Caufield
H.C. Wainwright
Buy
Reiterated
$18.00
+482.5%
11/04/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
$15.00
+385.4%
10/21/2026
Laura Chico
Wedbush
Buy
Maintained
$9.00
+191.3%
08/18/2026
Caroline Palomeque
Ladenburg Thalmann & Co.
Buy
Reiterated
$16.00
+417.8%
08/10/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Reiterated
$16.00
+417.8%
08/10/2026
Yigal Nochomovitz
Citi
Buy
Maintained
$11.00
+256%
08/10/2026
Christopher Raymond
Raymond James
Buy
Maintained
$15.00
+385.4%
08/07/2026
Unknown Analyst
Wedbush
Buy
Maintained
$19.00
+514.9%
07/13/2026
Dennis Ding
Jefferies
Buy
Maintained
$15.00
+385.4%
06/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
125.22M
94.47M
120.88M
127.66M
Cost of goods sold
33.70M
25.00M
31.86M
29.74M
Cost of revenue
33.70M
25.00M
31.86M
29.74M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
86.41M
102.27M
101.44M
93.89M
Operating expense
86.41M
102.27M
101.44M
93.89M
Total operating expenses
120.12M
127.27M
133.30M
123.63M
Operating income
5.10M
-32.79M
-12.42M
4.02M
Other non operating income
2.08M
2.11M
2.04M
2.71M
EBT including unusual items
-400.00K
-37.60M
-16.61M
-647.00K
EBT excluding unusual items
-400.00K
-37.60M
-16.61M
-647.00K
Income tax expense
7.00K
8.00K
110.00K
90.00K
Effective tax rate
-1.75%
-0.02%
-0.66%
-13.91%
Other operating expenses
-
-
-
-
Net income
-407.00K
-37.60M
-16.72M
-737.00K
Net profit margin
-0.33%
-39.80%
-13.83%
-0.58%
Earnings per share
-
-0.15
-0.07
-
Interest and investment income
-
-
-
-
Interest expense
-7.58M
-6.92M
-6.22M
-7.38M
Net interest expenses
-7.58M
-6.92M
-6.22M
-7.38M
Depreciation and amortization charges
-
-
-
-
EBITDA
6.02M
-31.88M
-11.82M
4.64M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps